Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 11241 clinical trials
test cancer API Toggle On

See protocol section 2 See protocol section 2 See protocol section 2. this is p tag. header

  • 0 views
  • 20 Feb, 2026
  • 1 location
Lorlatinib Combinations in Lung Cancer

This research study is evaluating Lorlatinib in combination with Crizotinib or Binimetinib as a possible treatment for either anaplastic lymphoma kinase (ALK)-positive lung cancer or ROS1-positive lung cancer. This research study involves three study drugs. Lorlatinib Binimetinib Crizotinib

levetiracetam
anti-epileptic
measurable disease
tubal ligation
leptomeningeal disease
  • 0 views
  • 16 Feb, 2024
  • 2 locations
TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer

This phase II trial studies how well TAS-102 and oxaliplatin work in treating patients with stage IV colon cancer. Drugs used in chemotherapy, such as TAS-102 and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or …

stage ivb colon cancer
tas-102
fluorouracil
absolute neutrophil count
measurable disease
  • 0 views
  • 16 Feb, 2024
  • 2 locations
Ipatasertib + Atezolizumab to Prevent Recurrence in TNBC

The purpose of this study is to determine if a combination of two drugs ipatasertib and atezolizumab works as a treatment for residual cancer in the breast or lymph nodes and have circulating tumor DNA in the blood. This research study involves the following investigational drugs: Ipatasertib Atezolizumab

gilbert's syndrome
cfdna
sentinel node
colony stimulating factor
hysterectomy
  • 0 views
  • 16 Feb, 2024
  • 1 location
cfDNA Methylation Assay for Clinical Evaluation of Patients With Stage IA Lung Cancer After Ablation Operation

The objective is to screen and monitor the efficacy of cfDNA methylation in patients with stage I lung cancer after ablation, to compare the similarities and differences of cfDNA methylation between surgical treatment and ablation in patients with stage I lung cancer, and to look for new indicators to assess …

chest ct
lung cancer
cfdna
cancer
ct scan chest
  • 0 views
  • 05 Aug, 2020
Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)

Control arm will be paclitaxel in combination with cetuximab, treatment included in the guidelines of the Spanish Society of Medical Oncology.

renal impairment
monoclonal antibodies
neuropathy
neck cancer
measurable disease
  • 0 views
  • 16 Feb, 2024
  • 20 locations
Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities

This phase I/II trial studies the side effects and best dose of cabozantinib when given with radiation therapy and how well it works in treating patients with sarcoma of the extremities. Cabozantinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving …

gilbert's syndrome
soft tissue sarcoma
oral contraceptives
metastasis
primary tumor
  • 0 views
  • 16 Feb, 2024
  • 1 location
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer

Participating in the program may improve knowledge and confidence about follow-up care, communication with cancer care and primary care doctors, and quality of life after cancer treatment in non-small cell lung cancer or colorectal cancer survivors.

stage iiib lung cancer ajcc v8
stage ii colorectal cancer ajcc v8
stage iiia lung cancer ajcc v8
stage ib lung cancer ajcc v8
stage iii lung cancer ajcc v8
  • 4 views
  • 16 Feb, 2024
  • 1 location
Combination Immunotherapy Targeting Sarcomas

The aim of this clinical trial is to assess the feasibility, safety and efficacy of a combination low dose chemotherapy and immunotherapy in patients who have sarcoma that is relapsed or late staged. Another goal of the study is to assess the safety and efficacy of the therapy that combines …

immunosuppressive
sarcoma
renal function
immunosuppression
creatinine clearance rate
  • 0 views
  • 16 Feb, 2024
  • 2 locations
CIML NK Cell in Head & Neck Cancer

This research study is evaluating the safety and efficacy of a combination drug and biologic therapy in patients with advanced head and neck cancer. This research study involves the following drugs and biologics: CIML NK donor cells IL-15 superagonist Ipilimumab

cancer
neck cancer
combination drug
combinations
biological therapy
  • 0 views
  • 16 Feb, 2024
  • 1 location